Latest Conference Articles

ADA 2020: FreeStyle Libre System Use Decreases Diabetic Ketoacidosis Rates

ADA 2020: FreeStyle Libre System Use Decreases Diabetic Ketoacidosis Rates

June 13th 2020

ADA Scientific Sessions

New findings from a study presented at the ADA’s 80th Scientific Sessions showed a dramatic drop in diabetic ketoacidosis hospitalizations in patients who used the FreeStyle Libre system

Technology-Enhanced Insulin Education by Pharmacists Prior to Hospital Discharge Boosts Patient Confidence

Technology-Enhanced Insulin Education by Pharmacists Prior to Hospital Discharge Boosts Patient Confidence

June 13th 2020

ADA Scientific Sessions

A poster presented at ADA’s 80th Scientific Sessions examines the effects of interactive pharmacist insulin teaching for patients with diabetes prior to hospital discharge.

Telehealth Program Enhances Engagement, Glycemic Control in Rural Patients With Diabetes

Telehealth Program Enhances Engagement, Glycemic Control in Rural Patients With Diabetes

June 13th 2020

ADA Scientific Sessions

Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.

ADA 2020: Pharmacists Can Improve Diabetes Outcomes in Rural Settings

ADA 2020: Pharmacists Can Improve Diabetes Outcomes in Rural Settings

June 12th 2020

ADA Scientific Sessions

An analysis focused on patients with type 2 diabetes in rural regions, where accessibility to physicians is often limited.

Cabozantinib With Nivolumab Extended PFS in Patients With Advanced Recurring Endometrial Cancer

Cabozantinib With Nivolumab Extended PFS in Patients With Advanced Recurring Endometrial Cancer

June 8th 2020

ASCO

The study, presented at the virtual ASCO20, showed significant clinical benefit for patients with endometrial cancer who were treated with cabozantinib and nivolumab.

Experts Examine the Many Factors of Pharmacist Burnout

Experts Examine the Many Factors of Pharmacist Burnout

June 5th 2020

APhA

“Are employers really stepping up to take care of their health providers? I think [that] is something that also probably needs to change.”

ASCO20: Switching to Generic Bortezomib Can Yield Significant Cost Savings

ASCO20: Switching to Generic Bortezomib Can Yield Significant Cost Savings

June 3rd 2020

ASCO

The study’s authors examined the opportunity to decrease the overall cost of bortezomib by $300-400 million by switching patients to the generic version.

Systematic Review Evaluates Cannabis, Cannabinoids in Palliative and Supportive Oncology Care

Systematic Review Evaluates Cannabis, Cannabinoids in Palliative and Supportive Oncology Care

May 30th 2020

ASCO

A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results. 

Adjuvant Osimertinib Therapy Delays Disease Recurrence in Localized NSCLC

Adjuvant Osimertinib Therapy Delays Disease Recurrence in Localized NSCLC

May 30th 2020

ASCO

Targeted therapy osimertinib (Tagrisso) demonstrated significant improvements in disease-free survival in patients with localized non-small cell lung cancer (NSCLC) who were treated following surgery.

ASCO20 Virtual: Pembrolizumab Doubles Progression-Free Survival for Certain Advanced Colorectal Cancer Types

ASCO20 Virtual: Pembrolizumab Doubles Progression-Free Survival for Certain Advanced Colorectal Cancer Types

May 29th 2020

ASCO

The study marks the first time that the drug has demonstrated benefit for front-line therapy in patients with this type of colorectal cancer.